Connor, Clark & Lunn Investment Management (CC&L)
ZYNE

Connor, Clark & Lunn Investment Management (CC&L)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,371
Closed -$146K – 1244
2021
Q3 		$146K Buy
+34,371
New +$146K ﹤0.01% 966